Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 425 of 1710 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/21
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 02/27/25
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 01/03/19
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 08/06/19
End: 09/25/20
Due: 09/25/21
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 01/22/20
Due: 01/22/21
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 12/26/19
Due: 12/26/20
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 12/31/14
Due: 12/31/15
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
Phase: N/A
Priority: Normal
Start: 05/21/21
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 08/18/17
Due: 08/18/18
Phase: N/A
Priority: Normal
Start: 06/30/00
End: 10/31/02
Due: 10/31/03
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 01/20/12
Due: 01/20/13
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 10/31/03
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 09/01/25
End: 12/01/27
Due: 12/01/28
Phase: N/A
Priority: Normal
Start: 09/07/21
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 03/17/22
Due: 03/17/23
Phase: N/A
Priority: Normal
Start: 11/09/10
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/10/19
End: 05/31/22
Due: 05/31/23